When combined with vancomycin, 70% of hamsters survived C. difficile challenge and only minor changes in microbiota composition were observed.159 Obeticholic acid is an antagonist of the farnesoid X receptor (FXR) and is approved as an orphan drug for the treatment of primary biliary cholangitis. Here, NR1H4 is linked to primary biliary cholangitis.